Paper39259459
In Vitro and in vivo characterization of nasal pH-Responsive in-situ hydrogel of Candesartan-loaded invasomes as a potential stroke treatment.
El-Housiny S and 6 others. Drug Deliv Transl Res, 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. In Vitro and in vivo characterization of nasal pH-Responsive in-situ hydrogel of Candesartan-loaded invasomes as a potential stroke treatment. Papers, record 39259459. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39259459
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- In Vitro and in vivo characterization of nasal pH-Responsive in-situ hydrogel of Candesartan-loaded invasomes as a potential stroke treatment.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Benzimidazoles | Major topic |
| Hydrogels | Major topic |
| Tetrazoles | Major topic |
| Stroke | Major topic |
| Animals | |
| Biphenyl Compounds | |
| Hydrogen-Ion Concentration | |
| Male | |
| Administration, Intranasal | |
| Rats | |
| Drug Liberation | |
| Rats, Sprague-Dawley | |
| Biological Availability | |
| Nasal Mucosa |
Source PubMed
References73
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36985306 | Synthesis of Carvacrol-Loaded Invasomes Nanoparticles Improved Acaricide Efficacy, Cuticle Invasion and Inhibition of Acetylcholinestrase against Hard Ticks. | Microorganisms | 2023 | https://conductscience.org/library/papers/36985306 | PubMed |
| 2 | 33209023 | Low-Frequency versus High-Frequency Ultrasound-Mediated Transdermal Delivery of Agomelatine-Loaded Invasomes: Development, Optimization and in-vivo Pharmacokinetic Assessment. | Int J Nanomedicine | 2020 | https://conductscience.org/library/papers/33209023 | PubMed |
| 3 | 19454737 | Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. | BMJ | 2009 | https://conductscience.org/library/papers/19454737 | PubMed |
| 4 | 34304580 | Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Study. | Hypertension | 2021 | https://conductscience.org/library/papers/34304580 | PubMed |
| 5 | 36117589 | Candesartan Reduces Neuronal Apoptosis Caused by Ischemic Stroke via Regulating the FFAR1/ITGA4 Pathway. | Mediators Inflamm | 2022 | https://conductscience.org/library/papers/36117589 | PubMed |
| 6 | 19788905 | The safety of chitosan as a pharmaceutical excipient. | Regul Toxicol Pharmacol | 2010 | https://conductscience.org/library/papers/19788905 | PubMed |
| 7 | 24865287 | Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation. | Drug Deliv | 2016 | https://conductscience.org/library/papers/24865287 | PubMed |
| 8 | 31900659 | Treatment of Basal Cell Carcinoma Via Binary Ethosomes of Vismodegib: In Vitro and In Vivo Studies. | AAPS PharmSciTech | 2020 | https://conductscience.org/library/papers/31900659 | PubMed |
| 9 | 34683853 | Improving the Antitumor Activity and Bioavailability of Sonidegib for the Treatment of Skin Cancer. | Pharmaceutics | 2021 | https://conductscience.org/library/papers/34683853 | PubMed |
| 10 | 28154100 | Stroke Caused by Atherosclerosis of the Major Intracranial Arteries. | Circ Res | 2017 | https://conductscience.org/library/papers/28154100 | PubMed |
| 11 | 22297749 | Ethosomes, binary ethosomes and transfersomes of terbinafine hydrochloride: a comparative study. | Arch Pharm Res | 2012 | https://conductscience.org/library/papers/22297749 | PubMed |
| 12 | 23444308 | Association of hypertension with stroke recurrence depends on ischemic stroke subtype. | Stroke | 2013 | https://conductscience.org/library/papers/23444308 | PubMed |
| 13 | 34506923 | Design of long acting invasomal nanovesicles for improved transdermal permeation and bioavailability of asenapine maleate for the chronic treatment of schizophrenia. | Int J Pharm | 2021 | https://conductscience.org/library/papers/34506923 | PubMed |
| 14 | 31360232 | Hypertension and Stroke: Update on Treatment. | Eur Cardiol | 2019 | https://conductscience.org/library/papers/31360232 | PubMed |
| 15 | 30726749 | Chitosan coated human serum albumin nanoparticles: A promising strategy for nose-to-brain drug delivery. | Int J Biol Macromol | 2019 | https://conductscience.org/library/papers/30726749 | PubMed |
| 16 | 31491483 | Development of an optimized avanafil-loaded invasomal transdermal film: Ex vivo skin permeation and in vivo evaluation. | Int J Pharm | 2019 | https://conductscience.org/library/papers/31491483 | PubMed |
| 17 | 19265050 | Candesartan augments ischemia-induced proangiogenic state and results in sustained improvement after stroke. | Stroke | 2009 | https://conductscience.org/library/papers/19265050 | PubMed |
| 18 | 21269482 | Comparison of dietary control and atorvastatin on high fat diet induced hepatic steatosis and hyperlipidemia in rats. | Lipids Health Dis | 2011 | https://conductscience.org/library/papers/21269482 | PubMed |
| 19 | 31323280 | Liposomes for drug delivery in stroke. | Brain Res Bull | 2019 | https://conductscience.org/library/papers/31323280 | PubMed |
| 20 | 27418824 | Charge effect of a liposomal delivery system encapsulating simvastatin to treat experimental ischemic stroke in rats. | Int J Nanomedicine | 2016 | https://conductscience.org/library/papers/27418824 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42458150 | Nose-to-brain delivery of candesartan-loaded nanoemulsion: brain biodistribution and neurobehavioral outcomes in controlled cortical impact-induced traumatic brain injury. | Inflammopharmacology | 2026 | https://conductscience.org/library/papers/42458150 | PubMed |
| 42414694 | Control of cardiotoxicity via nasal in-situ pH-sensitive transbilosomal formulation of candesartan. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/42414694 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39259459
GET https://conductscience.org/api/papers/v1/39259459/references?page=2